In order to analyze BNLF2a effects during the earliest phase of infection, we infected primary peripheral B cells with 2089 wild-type EBV or with the mutant viruses ΔBCRF1, ΔBNLF2a, or double k.o. and used them as targets for clonal CD8+ T cells. The gene discussed is CD8A; the disease is infection.